Augmentin and Movantik drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin (amoxicillin; clavulanate potassium) and Movantik (naloxegol oxalate). Common drug interactions include infusion site discomfort among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin and Movantik. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.

What is Movantik?

Movantik has active ingredients of naloxegol oxalate. It is often used in constipation. eHealthMe is studying from 3,523 Movantik users. Check the latest studies of Movantik.

On Aug, 04, 2026

26 people who take Augmentin and Movantik together, and have interactions are studied.

Augmentin and Movantik drug interactions.

What are the common drug interactions of Augmentin and Movantik, by gender? *:

female:

Infusion site discomfort
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Fall
Infusion site swelling
Pneumonia
Cardiac disorder
Cough
Fatigue (feeling of tiredness)
Pain

male:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Perineal abscess
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
Renal failure (kidney dysfunction)
Scrotal abscess (pus in scrotum)
Disability
Pneumonia
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Augmentin and Movantik, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Eye pain
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Abscess limb (limb infection)
Cellulitis (infection under the skin)
Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Perineal abscess
Perirectal abscess
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
Renal failure (kidney dysfunction)

60+:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac disorder
Arthralgia (joint pain)
Blood pressure decreased
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Fatigue (feeling of tiredness)
Immune system disorder
Pain
Swelling
Wound

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 10 people, 38.46%
Hypergammaglobulinaemia (elevated levels of gamma globulin): 6 people, 23.08%
Immune System Disorder: 5 people, 19.23%
Weight Decreased: 4 people, 15.38%
Type 2 Diabetes: 4 people, 15.38%
Hypotension (abnormally low blood pressure): 4 people, 15.38%
Neuropathy Peripheral (surface nerve damage): 3 people, 11.54%
Multiple Myeloma (cancer of the plasma cells): 3 people, 11.54%
Ulcerative Keratitis (ulcerative inflammation of the cornea): 2 people, 7.69%
Sleep Disorder: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin and Movantik?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously